Fecal pancreatic elastase testing measures the concentration of pancreatic elastase in stool to help assess exocrine pancreatic function. Pancreatic elastase is an enzyme produced by the pancreas and released into the duodenum. It remains stable during intestinal transit, making stool measurement useful as an indirect indicator of pancreatic enzyme secretion.1
What Is Exocrine Pancreatic Insufficiency?
Exocrine pancreatic insufficiency (EPI) occurs when insufficient pancreatic digestive enzymes reach the small intestine to support normal digestion. It can impair nutrient absorption and contribute to weight loss, malnutrition, and deficiencies in fat-soluble vitamins A, D, E, and K.2
Conditions and Symptoms Associated With EPI
Conditions associated with EPI include chronic pancreatitis, cystic fibrosis, and previous pancreatic surgery. Longstanding diabetes is also associated with increased risk. Symptoms can include fatty stools (steatorrhea), weight loss, bloating, and excessive gas.2
It’s important to note that symptoms alone do not establish EPI. Laboratory findings should also be considered alongside symptoms, nutritional status, and relevant medical history.
What Do Fecal Pancreatic Elastase Values Mean?
Fecal pancreatic elastase concentrations help assess exocrine pancreatic function. The following thresholds provide general interpretive guidance.
Fecal Pancreatic Elastase Concentration
General Interpretation
> 200 µg/g1
Generally considered within normal range
100-200 µg/g2
Indeterminate for EPI; further evaluation needed
<100 µg/g2
Suggestive of EPI
Results should be interpreted according to the applicable assay instructions and the laboratory’s established reporting criteria.
Fecal Elastase Testing: Practical Benefits and Limitations
Fecal pancreatic elastase testing is widely used as an initial, non-invasive assessment when EPI is suspected.2 Practical benefits include:
- Non-invasive collection: Measurement requires a stool sample rather than direct collection of pancreatic secretions.
- Supports EPI assessment: Provides a quantitative, indirect marker of exocrine pancreatic function.
However, there are some important limitations to consider, such as:
- Sample consistency matters: Testing requires semi-solid or solid stool. Watery specimens can dilute pancreatic elastase and produce falsely low concentrations.1,2
- Lower sensitivity in mild EPI: Testing may miss mild EPI, so a result within the normal range does not always exclude it.1
Measuring Fecal Pancreatic Elastase with IDK®’s ELISA
Immundiagnostik, Inc. offers the IDK® Pancreatic Elastase ELISA, an enzyme-linked immunosorbent assay for the quantitative determination of human pancreatic elastase in stool samples. The U.S. version is FDA Class 1 exempt and intended for in vitro diagnostic use by laboratory professionals. A Health Canada licensed version is also available.
View assay specifications and request the kit manual:
Additionally, the IDK® Pancreatic Elastase ELISA is compatible with the IDK Extract® Stool Sample Collection Tubes for simplified sample collection, preparation, and storage.
Have questions about assay requirements or stool sample preparation?
The IDK® Pancreatic Elastase ELISA is FDA Class 1 Exempt. For In Vitro Diagnostic Use. Health Canada Licensed. For Laboratory Professional Use Only.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
References
- Mayo Clinic Laboratories. (n.d.). ELASF – Overview: Pancreatic Elastase, Feces. Mayo Clinic Laboratories. Retrieved October 20, 2026, from https://www.mayocliniclabs.com/test-catalog/Overview/609492
- Whitcomb, D. C., Buchner, A. M., & Forsmark, C. E. (2023). AGA Clinical Practice Update on the Epidemiology, Evaluation, and Management of Exocrine Pancreatic Insufficiency: Expert Review. Gastroenterology, 165(5), 1292–1301. https://doi.org/10.1053/j.gastro.2023.07.007